GeoVax Labs (GOVX) News Today → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free GOVX Stock Alerts $1.72 +0.02 (+1.18%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15 at 8:59 AM | msn.comGeoVax Labs, Inc. (NASDAQ:GOVX) Q1 2024 Earnings Call TranscriptMay 15 at 8:10 AM | msn.comGOVX Stock Earnings: Geovax Labs Beats EPS for Q1 2024May 14 at 5:05 PM | finance.yahoo.comGeoVax Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 9, 2024 | americanbankingnews.comGeoVax Labs (NASDAQ:GOVX) Stock Price Up 0.6%April 5, 2024 | finanznachrichten.deGeoVax, Inc.: GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 VaccineMarch 28, 2024 | globenewswire.comGeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine CongressMarch 22, 2024 | investing.comGeoVax Labs Inc (GOVX)March 12, 2024 | globenewswire.comGeoVax to Present at the 36th Annual Roth ConferenceMarch 6, 2024 | globenewswire.comGeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing SystemMarch 2, 2024 | finance.yahoo.comGeoVax Labs, Inc. (NASDAQ:GOVX) Q4 2023 Earnings Call TranscriptMarch 1, 2024 | finanznachrichten.deGeoVax, Inc.: GeoVax Reports 2023 Year-End Financial Results and Provides Business UpdateFebruary 29, 2024 | globenewswire.comGeoVax Reports 2023 Year-End Financial Results and Provides Business UpdateFebruary 28, 2024 | benzinga.comEarnings Outlook For Geovax LabsFebruary 24, 2024 | msn.comGeoVax Labs (GOVX) Price Target Increased by 1170.83% to 77.78February 23, 2024 | msn.comInMed Pharmaceuticals And 2 Other Penny Stocks Insiders Are BuyingFebruary 22, 2024 | finance.yahoo.comGeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024February 22, 2024 | globenewswire.comGeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024February 20, 2024 | finance.yahoo.comGeoVax Labs, Inc. (GOVX)February 20, 2024 | uk.finance.yahoo.comGeoVax to Present at the 2024 BIO CEO & Investor ConferenceFebruary 19, 2024 | finance.yahoo.comGeoVax to Present at the 2024 BIO CEO & Investor ConferenceFebruary 19, 2024 | globenewswire.comGeoVax to Present at the 2024 BIO CEO & Investor ConferenceFebruary 1, 2024 | marketbeat.comTrading was temporarily halted for "GOVX" at 09:02 AM with a stated reason of "LULD pause."February 1, 2024 | marketbeat.comGeoVax Labs (NASDAQ:GOVX) Trading Down 13.1%GeoVax Labs (NASDAQ:GOVX) Shares Down 13.1%January 31, 2024 | marketbeat.comTrading was temporarily halted for "GOVX" at 07:01 PM with a stated reason of "News pending."January 29, 2024 | msn.comGeoVax Labs to effect 1-for-15 reverse stock split to regain compliance with Nasdaq ruleJanuary 8, 2024 | finanznachrichten.deGeoVax, Inc.: GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, OncologyJanuary 8, 2024 | finance.yahoo.comGeoVax Appoints Dr. Marc Pipas as Executive Medical Director, OncologyNovember 30, 2023 | finance.yahoo.comGeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine CongressNovember 29, 2023 | finance.yahoo.comGeoVax to Participate in Upcoming December Investor EventsNovember 28, 2023 | finance.yahoo.comGeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine CongressNovember 27, 2023 | msn.comGeovax Labs (GOVX) Price Target Increased by 12.50% to 6.12November 10, 2023 | finance.yahoo.comGeoVax Labs, Inc. (NASDAQ:GOVX) Q3 2023 Earnings Call TranscriptNovember 9, 2023 | finanznachrichten.deGeoVax, Inc.: GeoVax Reports Third Quarter 2023 Financial Results and Provides Business UpdateNovember 7, 2023 | benzinga.comGeovax Labs Earnings PreviewOctober 31, 2023 | finance.yahoo.comGeoVax to Report Third Quarter 2023 Financial Results and Provide Corporate Update on November 8, 2023October 24, 2023 | finance.yahoo.comGeoVax Update: Clinical and Operational Progress Toward Transformative OpportunitiesOctober 5, 2023 | finanznachrichten.deGeoVax, Inc.: GeoVax Receives Notice of Allowance for HIV Vaccine PatentSeptember 27, 2023 | finance.yahoo.comGeoVax to Participate in Upcoming October Investor and Industry EventsSeptember 26, 2023 | markets.businessinsider.comGeoVax Labs Secures License Agreement With ProBioGenSeptember 19, 2023 | finance.yahoo.comGeoVax Next-Generation COVID-19 Vaccine Demonstrates Potent Antibody and Cellular Immunity in Immunocompromised PatientsSeptember 12, 2023 | finance.yahoo.comGeoVax Presents Corporate Update at the H.C. Wainwright 25th Annual Global Investment ConferenceSeptember 11, 2023 | finance.yahoo.comGeoVax Completes Enrollment of Phase 2 Trial for Next-Generation COVID-19 Vaccine BoosterAugust 31, 2023 | msn.comGeovax Labs (GOVX) Price Target Increased by 11.11% to 6.12August 31, 2023 | finance.yahoo.comGeoVax to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceAugust 28, 2023 | finanznachrichten.deGeoVax, Inc.: GeoVax Receives Notice of Allowance for Malaria Vaccine PatentAugust 11, 2023 | finance.yahoo.comGeoVax Labs, Inc. (NASDAQ:GOVX) Q2 2023 Earnings Call TranscriptJuly 26, 2023 | finance.yahoo.comGeoVax to Report Second Quarter 2023 Financial Results and Provide Corporate Update on Wednesday, August 9, 2023July 24, 2023 | markets.businessinsider.comGeoVax Labs (GOVX) Gets a Buy from Noble FinancialJuly 24, 2023 | finance.yahoo.comGeoVax Announces Issuance of Ebola Vaccine PatentJuly 20, 2023 | finanznachrichten.deGeoVax, Inc.: GeoVax Announces Initiation of Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia Get GeoVax Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for GOVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Amazon's betting big on this unknown AI company (Ad)Amazon's Betting Big on This Unknown AI Company Amazon has just made a stunning $144 million investment in one small AI company. Discover why this company GOVX Media Mentions By Week GOVX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GOVX News Sentiment▼0.470.55▲Average Medical News Sentiment GOVX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GOVX Articles This Week▼71▲GOVX Articles Average Week Get GeoVax Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for GOVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BCEL News Today PHIO News Today ALZN News Today REVB News Today CLVR News Today EVOK News Today ARTL News Today ENSC News Today LGVN News Today SNGX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GOVX) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsTop 5 AI Stocks to Buy for 2024Market Moving TrendsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportPharma Giant Makes Deal with a "Drug Smuggler"Behind the MarketsTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeoVax Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.